Beatriz Giraldez-Gonzalez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Journal: Epilepsia

Published: November 04, 2025

Epileptic and developmental encephalopathy secondary to inversion-duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes.

Epileptic and developmental encephalopathy secondary to inversion-duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes.

Journal: Epilepsia

Published: September 29, 2025

The natural history of CDKL5 deficiency disorder into adulthood.

The natural history of CDKL5 deficiency disorder into adulthood.

Journal: medRxiv : the preprint server for health sciences

Published: January 27, 2025

Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences.

Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences.

Journal: Neurology

Published: September 24, 2021

De novo truncating mutation in SCN1A as a cause of febrile seizures plus (FS+).

De novo truncating mutation in SCN1A as a cause of febrile seizures plus (FS+).

Journal: Epileptic disorders : international epilepsy journal with videotape

Published: June 17, 2020

Erratum to "Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study" [Epilepsy Res. 126 (2016) 201-210].

Erratum to "Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study" [Epilepsy Res. 126 (2016) 201-210].

Journal: Epilepsy research

Published: December 27, 2016

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.

Journal: Epilepsy research

Published: December 23, 2015

Early add-on lacosamide in a real-life setting: results of the REALLY study.

Early add-on lacosamide in a real-life setting: results of the REALLY study.

Journal: Clinical drug investigation

Published: December 10, 2014

Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.

Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.

Journal: Epilepsy & behavior : E&B

Published: May 14, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026